CIPROFLOXACIN Injection, USP

Electronic Catalog

WARNING:
Fluoroquinolones, including CIPROFLOXACIN Injection, USP, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants (See WARNINGS).

See larger image

LATEX-FREE • PRESERVATIVE-FREE • AP RATED

Brand Name Equivalent: CIPRO I.V.
Therapeutic Category: Anti-infectives/Antibacterial

Consider these SAGENT benefits:
• Available in:
      • 200 mg premix bags
      • 400 mg premix bags
• Enhanced packaging
      • Ready-to-use convenience
      • Bar coding
• LATEX-FREE

Important Ciprofloxacin Safety Information for U.S. Healthcare Professionals and Patients:
• Ciprofloxacin Package Insert

• Ciprofloxacin Medication Guide

NDC #25021	Description	Strength	Fill Volume	Concentration	Container Size	Closure	Unit of Sale	Package Insert	Storage Requirements	Product Photos	360^o View
114-82	Premix Bag	200 mg	100 mL	2 mg per mL	N/A	N/A	10
114-87	Premix Bag	400 mg	200 mL	2 mg per mL	N/A	N/A	10

MSDS Sheet Bar Codes Wholesaler Item Numbers


[Back to Products page]	This product information is intended for U.S. residents only. All trademarks and registered trademarks are the property of their respective owners.